Stay updated on A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Sign up to get notified when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.

Latest updates to the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page
- Check5 days agoChange DetectedDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check34 days agoChange DetectedAdds revision tag v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag (v3.0.2).SummaryDifference0.5%

- Check48 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, with removal of the Back to Top link. No substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check62 days agoChange DetectedThe webpage has been updated to include new drug information for Odevixibat and additional related topics, while also removing some previous location details and references to genetic disease resources.SummaryDifference4%

Stay in the know with updates to A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.